New dialysis device for kids: a safer way to clean blood?

NCT ID NCT06603324

Not yet recruiting Disease control Sponsor: Fresenius Medical Care Deutschland GmbH Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a special dialysis machine, the MultiFiltratePRO, in children with acute kidney failure. The goal is to see if it can deliver at least 80% of the prescribed treatment within 72 hours while being safe. About 43 children weighing between 8 and 40 kilograms will be treated for up to 10 days, and doctors will watch for side effects like low blood pressure or electrolyte problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MultiFiltratePRO device for continuous venovenous hemodiafiltration (CVVHD)
What this could lead to: If successful, this could confirm that the MultiFiltratePRO device safely and effectively delivers dialysis to children, improving care for pediatric kidney failure.
What could go wrong: This is a small, early-stage study with only 43 participants, so results may not apply to all children. Risks include side effects like low blood pressure or electrolyte imbalances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CVVHD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CVVHD RENAL FAILURE

Contacts and locations

Locations

Universitätsklinikum Frankfurt

Frankfurt, 60590, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.